Can Bill Gruber Take Solace Where He Took Interlace?
Author
Healthegy
Published
Thu 02 Jul 2015
Episode Link
None
Solace Therapeutics CEO Bill Gruber hopes to repeat the successful exit he helped execute when Hologic paid close to $300 million for his previous company Interlace.
